Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
2015
Critical review: vegetables and fruit in the prevention of chronic diseases
2012 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
2013 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis
1999
Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone
2004
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians
2017
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Vitamin D Deficiency
2007 Standout
Osteoporosis in men with prostate carcinoma receiving androgen‐deprivation therapy
2004
Osteoporosis: now and the future
2011 Standout
Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures
2004
Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment
2004
Prevention and treatment of osteoporosis in inflammatory bowel disease
2006
Potential of alfacalcidol for reducing increased risk of falls and fractures
2009
Biochemical Markers of Bone Turnover in the Clinical Development of Drugs for Osteoporosis and Metastatic Bone Disease
2006
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
2003
Chronic arthritis leads to disturbances in the bone collagen network
2010 StandoutNobel
The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation
2006
Cancer treatment and survivorship statistics, 2012
2012 Standout
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
2007
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Intravenous ibandronate injections in postmenopausal women with osteoporosis: One‐year results from the dosing intravenous administration study
2006
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
2010
Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)
2007
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
2009
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Towards a diagnostic and therapeutic consensus in male osteoporosis
2011
The structural basis of bone fragility in men
1999
Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trial
2009
Consensus statement on diagnosis and clinical management of Klinefelter syndrome
2010
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
Basic and clinical aspects of osteoporosis in inflammatory bowel disease
2007
Osteoporosis in Men
2008
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Interventions for enhancing medication adherence
2008 Standout
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
2006 Standout
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
2000
Osteoporosis in Men
2008
Bone fragility in men - where are we?
2006
Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta‐Analysis
2016
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Interventions for enhancing medication adherence
2014 Standout
Treatment of established osteoporosis: a systematic review and cost-utility analysis
2002
Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
2012
Basic and clinical aspects of osteoporosis in inflammatory bowel disease
2007
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
2008
Addressing unmeasured confounding in comparative observational research
2018 StandoutNobel
Interventions for preventing falls in older people living in the community
2012 Standout
Works of A. Dorst being referenced
Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study
2005
Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study
2005
Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study
2003
Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study
2004
Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis
2004
Avoidance of Vertebral Fractures in Men with Idiopathic Osteoporosis by a Three Year Therapy with Calcium and Low-Dose Intermittent Monofluorophosphate
1998
Alendronate Treatment of Established Primary Osteoporosis in Men: Results of a 2-Year Prospective Study
2001
Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study
2008